Croquette Magali, Larrieu Ardilouze Elisa, Beaufort Corinne, Jutant Etienne-Marie, Puyade Matthieu, Montani David, Thollot Cécile, Lanéelle Damien, De Géa Marion, Trihan Jean-Eudes
Vascular Medicine Unit, CHU de Poitiers, Poitiers, France.
Cardiology Department, CHU de Poitiers, Poitiers, France.
ERJ Open Res. 2025 Jun 30;11(3). doi: 10.1183/23120541.01027-2024. eCollection 2025 May.
Elevated right atrial pressure (RAP) is associated with poor prognosis regarding 1-year mortality in pulmonary hypertension (PH) patients. Unfortunately, there is currently no reliable non-invasive technique for estimating RAP in PH patients. Recently, femoral venous stasis index (FVSI) has been described as highly correlated with RAP in PH patients. Our main goal was to confirm the diagnostic accuracy of FVSI for estimating RAP.
In this prospective study, we included 101 patients with suspected or known PH undergoing right heart catheterisation for 18 months.
FVSI was highly correlated with RAP (r=0.77, p<0.001). With a cut-off of 0.18, FVSI can exclude RAP >8 mmHg with 89% sensitivity (area under the receiver operating characteristic curve (AUROC) 0.88) and, with a cut-off of 0.45, can confirm RAP >14 mmHg with 93% specificity (AUROC 0.93). During a 2-year follow-up, the composite end-point (hospitalisation, increase in PH treatment and all-cause death) occurred in 32 patients (31.7%). FVSI predicted PH morbidity/mortality (FVSI ≥0.45 <0.18: HR 8.37 (95% CI 2.84-24.7); p<0.001). Inter-observer reproducibility between junior and senior operators was excellent (intraclass correlation coefficient 0.97 (95% CI 0.95-0.98)).
We propose FVSI as a rapid, simple, non-invasive tool for estimating RAP and which may be of additional prognostic interest in terms of PH-related morbi-mortality.
右心房压力(RAP)升高与肺动脉高压(PH)患者1年死亡率的不良预后相关。不幸的是,目前尚无可靠的非侵入性技术来估计PH患者的RAP。最近,股静脉淤滞指数(FVSI)已被描述为与PH患者的RAP高度相关。我们的主要目标是确认FVSI估计RAP的诊断准确性。
在这项前瞻性研究中,我们纳入了101例疑似或已知PH的患者,这些患者接受了18个月的右心导管检查。
FVSI与RAP高度相关(r = 0.77,p < 0.001)。截断值为0.18时,FVSI可排除RAP>8 mmHg,灵敏度为89%(受试者工作特征曲线下面积(AUROC)为0.88);截断值为0.45时,可确认RAP>14 mmHg,特异度为93%(AUROC为0.93)。在2年的随访期间,32例患者(31.7%)出现了复合终点(住院、PH治疗增加和全因死亡)。FVSI可预测PH的发病/死亡(FVSI≥0.45 <0.18:风险比8.37(95%可信区间2.84 - 24.7);p < 0.001)。初级和高级操作人员之间的观察者间可重复性极佳(组内相关系数0.97(95%可信区间0.95 - 0.98))。
我们建议将FVSI作为一种快速、简单的非侵入性工具来估计RAP,并且就PH相关的发病死亡率而言,它可能具有额外的预后价值。